Can Integra LifeSciences Holdings Corporation (NASDAQ:IART) Continue To Move The Needle? Shares to Grow 12.02%

Analysts are projecting Integra LifeSciences Holdings Corporation (NASDAQ:IART) to grow at an accelerated rate over the next five years.  Sell-side analysts are looking for the company to grow 12.02% over the next year and 13.48% over the next five years.

Trying to extract profits from the stock market is not the easiest of tasks. In fact, it can be quite difficult. Amateur traders may be faced with tough challenges right out of the gate. Some traders may experience some crushing blows, and they have to figure out early on how to steady the ship. Completing all the necessary research can help the trader build a solid foundation, but when the rubber hits the road, it may take more than that just to stay afloat. Developing the proper mindset can be one of the biggest contributing factors for success in trading the stock market. This may take some time to achieve, but it may make all the difference when attempting to reach the goal of long lasting success.

EPS measures what each share is worth and also indicates how much money their sharehoders would gain if the company was to pay out all of its profits.  Integra LifeSciences Holdings Corporation’s trailing 12- months EPS is 0.72.  Last year, their EPS growth was -47.00% and their EPS growth over the past five years was 31.60%.  


Let’s start off by taking a look at how the stock has been performing recently.  Over the past twelve months, Integra LifeSciences Holdings Corporation (NASDAQ:IART)’s stock was 19.38%.  Last week, it was -1.08%, 18.30% over the last quarter, and  -10.48% for the past half-year. 

Over the past 50 days, Integra LifeSciences Holdings Corporation stock was -6.56% off of the high and 15.64% removed from the low.  Their 52-Week High and Low are noted here.  -20.24% (High), 27.76%, (Low). 


Integra LifeSciences Holdings Corporation (NASDAQ:IART)’s performance this year to date is 19.38%.  The stock has performed -1.08% over the last seven days, -4.10% over the last thirty, and 18.30% over the last three months.  Over the last six months, Integra LifeSciences Holdings Corporation’s stock has been -10.48% and -3.50% for the year.


Wall Street analysts are have a consensus analyst recommendation of 2.40 on the stock.  This is based on a 1-5 scale where 1 represents a Strong Buy and 5 a Strong Sell.  Brokerages covering the name have a $60.79 on the stock.

Most experienced traders understand how unpredictable the market can be. The market is its own kind of beast that does not care whether the trader makes money or not. Because there are so many different possible trading strategies to use, it can be extremely tough to find one that works. There may be times when traders become overwhelmed with the craziness of daily market action. Wandering through turbulent market climates may require increased discipline and patience. It can be highly tempting for traders to jump into a position based on can’t miss stock tips. Having the patience to make quality, informed trades, may end up helping the trader immensely.

The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs.  Where quoted, past performance is not indicative of future performance.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.